Accéder au contenu
MilliporeSigma

Protective effects of mildronate in an experimental model of type 2 diabetes in Goto-Kakizaki rats.

British journal of pharmacology (2009-07-15)
Edgars Liepinsh, Reinis Vilskersts, Liga Zvejniece, Baiba Svalbe, Elina Skapare, Janis Kuka, Helena Cirule, Solveiga Grinberga, Ivars Kalvinsh, Maija Dambrova
RÉSUMÉ

Mildronate [3-(2,2,2-trimethylhydrazinium) propionate] is an anti-ischaemic drug whose mechanism of action is based on its inhibition of L-carnitine biosynthesis and uptake. As L-carnitine plays a pivotal role in the balanced metabolism of fatty acids and carbohydrates, this study was carried out to investigate whether long-term mildronate treatment could influence glucose levels and prevent diabetic complications in an experimental model of type 2 diabetes in Goto-Kakizaki (GK) rats. GK rats were treated orally with mildronate at doses of 100 and 200 mg.kg(-1) daily for 8 weeks. Plasma metabolites reflecting glucose and lipids, as well as fructosamine and beta-hydroxybutyrate, were assessed. L-carnitine concentrations were measured by ultra performance liquid chromatography with tandem mass spectrometry. An isolated rat heart ischaemia-reperfusion model was used to investigate possible cardioprotective effects. Pain sensitivity was measured with a tail-flick latency test. Mildronate treatment significantly decreased L-carnitine concentrations in rat plasma and gradually decreased both the fed- and fasted-state blood glucose. Mildronate strongly inhibited fructosamine accumulation and loss of pain sensitivity and also ameliorated the enhanced contractile responsiveness of GK rat aortic rings to phenylephrine. In addition, in mildronate-treated hearts, the necrosis zone following coronary occlusion was significantly decreased by 30%. These results demonstrate for the first time that in GK rats, an experimental model of type 2 diabetes, mildronate decreased L-carnitine contents and exhibited cardioprotective effects, decreased blood glucose concentrations and prevented the loss of pain sensitivity. These findings indicate that mildronate treatment could be beneficial in diabetes patients with cardiovascular problems.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Albumine de sérum bovin, heat shock fraction, protease free, fatty acid free, essentially globulin free, pH 7, ≥98%
Sigma-Aldrich
Albumine de sérum bovin, lyophilized powder, ≥96% (agarose gel electrophoresis)
Sigma-Aldrich
Albumine de sérum bovin, heat shock fraction, pH 7, ≥98%
Sigma-Aldrich
Albumine de sérum bovin, lyophilized powder, BioReagent, suitable for cell culture
Sigma-Aldrich
Albumine de sérum bovin, fatty acid free, low endotoxin, lyophilized powder, BioReagent, suitable for cell culture, ≥96% (agarose gel electrophoresis)
Sigma-Aldrich
Albumine de sérum bovin, heat shock fraction, protease free, essentially globulin free, pH 7, ≥98%
Sigma-Aldrich
Albumine de sérum bovin, heat shock fraction, protease free, pH 7, ≥98%
Sigma-Aldrich
Albumine de sérum bovin, cold ethanol fraction, pH 5.2, ≥96%
Sigma-Aldrich
Albumine de sérum bovin, lyophilized powder, essentially fatty acid free, ≥96% (agarose gel electrophoresis)
Sigma-Aldrich
Albumine de sérum bovin, heat shock fraction, pH 5.2, ≥96%
Sigma-Aldrich
Albumine de sérum bovin, heat shock fraction, suitable for RIA, pH 5.2, ≥96%
Sigma-Aldrich
Albumine de sérum bovin, heat shock fraction, lyophilized powder, essentially fatty acid free, ≥98% (agarose gel electrophoresis)
Sigma-Aldrich
Albumine de sérum bovin, lyophilized powder, essentially globulin free, ≥99% (agarose gel electrophoresis)
Sigma-Aldrich
Albumine de sérum bovin, lyophilized powder, essentially IgG-free, low endotoxin, BioReagent, suitable for cell culture
Sigma-Aldrich
Albumine de sérum bovin, lyophilized powder, low endotoxin, BioReagent, suitable for cell culture, ≥98% (agarose gel electrophoresis)
Sigma-Aldrich
Albumine de sérum bovin, lyophilized powder, suitable for (for molecular biology), Non-acetylated
Sigma-Aldrich
Albumine de sérum bovin, lyophilized powder, essentially fatty acid free and essentially globulin free, ≥99% (agarose gel electrophoresis)
Sigma-Aldrich
Albumine de sérum bovin, powder, BioXtra
Sigma-Aldrich
Albumine de sérum bovin, heat shock fraction, pH 7, ≥98%
Sigma-Aldrich
Albumine de sérum bovin, heat shock fraction, pH 5.2, ≥96%
Sigma-Aldrich
Albumine de sérum bovin, lyophilized powder, protease, essentially free, ≥98% (agarose gel electrophoresis)
Sigma-Aldrich
Albumine de sérum bovin, heat shock fraction, protease free, suitable for hybridization, pH 7, ≥98%
Sigma-Aldrich
Albumine de sérum bovin, lyophilized powder, Essentially fatty acid free
Sigma-Aldrich
Albumine de sérum bovin, Cohn Fraction V, lyophilized powder, ≥96% (agarose gel electrophoresis)
Sigma-Aldrich
Albumine de sérum bovin, pH <5.0, powder
Sigma-Aldrich
Albumine de sérum bovin, lyophilized powder, essentially globulin free, BioReagent, suitable for cell culture
Sigma-Aldrich
Albumine de sérum bovin, heat shock fraction, protease free, low endotoxin, suitable for cell culture, pH 7, ≥98%
Sigma-Aldrich
Albumine de sérum bovin, chromatographically purified, New Zealand origin, low endotoxin, suitable for cell culture, pH 7, ≥98%
Sigma-Aldrich
Albumine de sérum bovin, lyophilized powder, essentially globulin free, low endotoxin, ≥98% (agarose gel electrophoresis)
Sigma-Aldrich
Albumine de sérum bovin, lyophilized powder, ≥98% (agarose gel electrophoresis)